Marginalized two part model for analyzing multilevel semicontinuous medical costs in Iranian households.

Sci Rep

Department of Biostatistics and Epidemiology, School of Health, Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Published: March 2025

Medical costs (MCs) represent a significant burden on household finances and often lead to economic challenges. This study analyzed the data of 8,993 Iranian households from 2021 collected by the Iranian Statistical Center. Using a marginalized two-part model (MTP) with lognormal and gamma distributions, the relationship between MCs and factors such as age, gender, education, and household characteristics was examined. A two-level structure was applied to account for heterogeneity across provinces, with analyzes performed using R software. The mean annual MC was $180 with high variability (SD = $324.39). The main determinants included family size, residence area, education level, and socioeconomic status. Single households and families with more students had lower MCs. Among the models evaluated, the MTP-Lognormal model (MTP-LN) performed better than the MTP-Gamma model (MTP-G), as it provided better predictive accuracy and better reflected cost differences between province. These results highlight the socio-economic and demographic factors that influence household MCs in Iran. The MTP-LN model provides valuable insights for identifying at-risk groups and developing targeted interventions to reduce the financial burden of healthcare, especially for vulnerable populations. This study emphasizes the importance of tailored interventions to address regional inequalities and promote equitable access to healthcare.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876334PMC
http://dx.doi.org/10.1038/s41598-025-91309-0DOI Listing

Publication Analysis

Top Keywords

medical costs
8
iranian households
8
marginalized model
4
model analyzing
4
analyzing multilevel
4
multilevel semicontinuous
4
semicontinuous medical
4
costs iranian
4
households medical
4
mcs
4

Similar Publications

The human genome project ushered in a genomic medicine era that was largely unimaginable three decades ago. Discoveries of druggable cancer drivers enabled biomarker-driven gene- and immune-targeted therapy and transformed cancer treatment. Minimizing treatment not expected to benefit, and toxicity-including financial and time-are important goals of modern oncology.

View Article and Find Full Text PDF

Background And Objective: Invasive meningococcal disease (IMD) is an uncommon but serious disease associated with a risk of death and severe long-term sequelae, impacting both patients and their caregivers. Productivity losses due to IMD have not previously been comprehensively evaluated in the USA. This study evaluated both market and non-market productivity losses to better estimate the economic burden of IMD in the USA.

View Article and Find Full Text PDF

Introduction: Opioid-induced constipation (OIC) is a common side effect of chronic opioid therapy that significantly impacts quality of life and healthcare costs. Naldemedine, a peripherally acting mu-opioid receptor antagonist, has shown efficacy in treating OIC. However, real-world evidence on naldemedine use in the United States is limited, particularly in older adults.

View Article and Find Full Text PDF

Few studies explore the burden of mild-to-moderate atopic dermatitis (AD). We aimed to investigate disease burden in mild-to-moderate AD using real-world data from adults with AD and their physicians in the United States. Data were drawn from the Adelphi Real World AD Disease Specific Programme™, a cross-sectional survey of physicians and their patients with AD in real-world clinical practice in the US from November 2014 to February 2015.

View Article and Find Full Text PDF

Urticaria has become a major public health challenge in China, yet comprehensive national data assessments are lacking. This study analyzes the burden of urticaria in China compared to G20 countries from 1990 to 2021. Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we examined the incidence, prevalence, and disability-adjusted life years (DALYs) of urticaria by age and sex in China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!